(E)-N-benzylidene-1-(4-methoxyphenyl)methanamine | 206768-78-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: (E)-N-benzylidene-1-(4-methoxyphenyl)methanamine
• 英文别名: (E)-N-[(4-methoxyphenyl)methyl]-1-phenylmethanimine；(E)-N-(4-methoxybenzyl)-1-phenylmethanimine；benzylidene-(4-methoxybenzyl)-amine；N-benzylidene-4-methoxybenzylamine；(4-methoxy-benzyl)-[1-phenyl-meth-(E)-ylidene]-amine；(4-methoxy-benzyl)-[1-phenyl-meth-(E)-ylidene]amine
• CAS: 206768-78-7
• 化学式: C₁₅H₁₅NO
• 分子量: 225.29
• InChiKey: UHERNABOIPEDIY-LFIBNONCSA-N

物化性质

• 沸点：
  160-165 °C(Press: 0.1 Torr)
• 密度：
  0.99±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.31
• 重原子数：
  17.0
• 可旋转键数：
  4.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  21.59
• 氢给体数：
  0.0
• 氢受体数：
  2.0

反应信息

• 作为反应物：
  描述：

  (E)-N-benzylidene-1-(4-methoxyphenyl)methanamine 在 4-二甲氨基吡啶 、 dipotassium hydrogenphosphate 、 dipotassium peroxodisulfate 、 三乙胺 作用下， 以 乙醚 、 二氯甲烷 、 水 、 乙腈 为溶剂， 反应 9.17h， 生成 tert-butyl (3R,4S)-3-[(1S)-2-methyl-1-(phenylmethoxycarbonylamino)propyl]-2-oxo-4-phenylazetidine-1-carboxylate
  参考文献：
  名称：

  Cycloadditions of Ketenes Generated in the Wolff Rearrangement. Stereoselective Synthesis of Aminoalkyl-Substituted β-Lactams from α-Amino Acids

  摘要：

  Diazo ketones 1-16, derived from suitable protected amino acids (Ala, Leu, Val, Ile, Tie, Phe, Pro, Orn, Lys, Ser, and Thr), have been photochemically rearranged, leading to the corresponding ketene intermediates. They were trapped with N-benzylbenzaldimine 17 to give beta-lactams S-SS in up to 90% yield. In these cycloadditions, two of the four possible diastereoisomers were formed exclusively. The selectivity ranged from 60:40 to 93:7 and the bulkiness of the parent amino acid side chain is the governing factor. The relative configuration was-proved by three X-ray crystal structures. The diastereoselectivity in these reactions is also influenced by the use of chiral N-phenethylbenzaldimines 34 and 35. With regard to a projected deprotection of the lactam-nitrogen, N-allyl- (49) and N-(p-methoxybenzyl)benzaldimine (44) were used in this reaction. This led to the N-allyl beta-lactams 50 and 51 in 62 and 56% yield, respectively, and to the p-methoxybenzyl-substituted beta-lactams 45 and 46 (50 and 72% yield). The p-methoxybenzyl, group on the valine-derived beta-lactam 45a can be cleaved with potassium peroxodisulfate in 63% yield.

  DOI：

  10.1021/jo9705069
• 作为产物：
  描述：

  [(E)-4-Methoxy-benzylimino]-phenyl-acetic acid 以 苯 为溶剂， 反应 0.5h， 生成 (E)-N-benzylidene-1-(4-methoxyphenyl)methanamine
  参考文献：
  名称：

  α-酮酸的亚胺已准备好脱羧。硫酰胺合成的机理及应用

  摘要：

  即使发生亚胺-烯胺异构化反应，α-酮基ids也很容易通过亚胺与伯胺和/或仲胺的形成而被羧化。该方法非常复杂，涉及一种中间体两性离子，该两性离子可被硫捕获，从而以优异的收率得到硫代酰胺。

  DOI：

  10.1039/c39850001523

文献信息

• [EN] TRICYCLIC MODULATORS OF TNF SIGNALING<br/>[FR] MODULATEURS TRICYCLIQUES DE LA SIGNALISATION DU TNF
  申请人：ABBVIE INC

  公开号：WO2016168641A1

  公开（公告）日：2016-10-20

  The invention provides tricyclic heterocyclic compounds, pharmaceutically acceptable salts, prodrugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention may be useful for treating immunological and oncological conditions.

  这项发明提供了三环杂环化合物，其药用盐、前药、生物活性代谢物、立体异构体和同分异构体，其中变量在此处定义。该发明的化合物可能对治疗免疫和肿瘤疾病有用。
• Synthetic and Mechanistic Studies of Indium-Mediated Allylation of Imines in Ionic Liquids
  作者：Man Chun Law、Tin Wai Cheung、Kwok-Yin Wong、Tak Hang Chan

  DOI：10.1021/jo062198x

  日期：2007.2.1

  Aldimines derived from aryl and non-enolizable aliphatic aldehydes were allylated with allyl bromide mediated by indium powder in [bpy][BF4] (bpy = N-butylpyridine) to give good yields of the corresponding homoallylic amines. Selective formation of monoallylated amines can be achieved by varying the amount of bromide ion additive in the form of [bpy][Br]. The transient organoindium intermediates, allylindium(I)

  在[bpy] [BF 4 ]（bpy = N-丁基吡啶）中，将铟粉介导的烯丙基溴与烯丙基溴烯丙基化衍生自芳基和不可烯化的脂肪族醛的醛亚胺，以得到相应的均烯丙基胺良好的收率。可以通过改变[bpy] [Br]形式的溴离子添加剂的数量来实现单烯丙基化胺的选择性形成。通过NMR光谱研究了反应中形成的瞬态有机铟中间体，烯丙基（I）和烯丙基（III）二溴化物。
• <i>o</i>-Iodoxybenzoic Acid (IBX) as a Viable Reagent in the Manipulation of Nitrogen- and Sulfur-Containing Substrates:  Scope, Generality, and Mechanism of IBX-Mediated Amine Oxidations and Dithiane Deprotections
  作者：K. C. Nicolaou、Casey J. N. Mathison、Tamsyn Montagnon

  DOI：10.1021/ja0400382

  日期：2004.4.28

  o-Iodoxybenzoic acid (IBX), a highly versatile hypervalent iodine(V) reagent, was found to efficiently mediate the dehydrogenation of amines in addition to facilitating the oxidative cleavage of dithioacetals and dithioketals. Through the development of relevant IBX-based protocols, a plethora of useful synthetic intermediates, including imines, oximes, ketones, and aromatic N-heterocycles, were found

  发现邻碘苯甲酸 (IBX) 是一种用途广泛的高价碘 (V) 试剂，除了促进二硫缩醛和二硫缩酮的氧化裂解外，还可以有效介导胺的脱氢。通过开发相关的基于 IBX 的协议，发现大量有用的合成中间体，包括亚胺、肟、酮和芳香族 N-杂环，在特别温和的条件下很容易获得。对这些转化的进一步研究导致了对有价值的机械细节的阐明，从而得出结论，它们是通过离子而不是单电子转移 (SET) 途径进行的。
• PYRIDO PYRIMIDINES
  申请人：Anderson Kevin

  公开号：US20120184542A1

  公开（公告）日：2012-07-19

  Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer, Down syndrome or early onset Alzheimer's disease.

  具有该公式的化合物以及它们的药用可接受盐被描述，以及包含所述化合物及其药用可接受盐的药物组合物，以及所述化合物和药物组合物用于治疗、控制或改善增生性疾病，包括癌症、唐氏综合症或早发性阿尔茨海默病的使用。
• [EN] MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS<br/>[FR] COMPLEXES À BASE DE MANGANÈSE ET LEURS UTILISATIONS SERVANT À UNE CATALYSE HOMOGÈNE
  申请人：YEDA RES & DEV

  公开号：WO2017137984A1

  公开（公告）日：2017-08-17

  The present invention relates to novel manganese complexes and their use, inter alia, for homogeneous catalysis in (1) the preparation of imine by dehydrogenative coupling of an alcohol and amine; (2) C-C coupling in Michael addition reaction using nitriles as Michael donors; (3) dehydrogenative coupling of alcohols to give esters and hydrogen gas (4) hydrogenation of esters to form alcohols (including hydrogenation of cyclic esters (lactones) or cyclic di-esters (di- lactones), or polyesters); (5) hydrogenation of amides (including cyclic dipeptides, lactams, diamide, polypeptides and polyamides) to alcohols and amines (or diamine); (6) hydrogenation of organic carbonates (including polycarbonates) to alcohols or hydrogenation of carbamates (including polycarbamates) or urea derivatives to alcohols and amines; (7) dehydrogenation of secondary alcohols to ketones; (8) amidation of esters (i.e., synthesis of amides from esters and amines); (9) acylation of alcohols using esters; (10) coupling of alcohols with water and a base to form carboxylic acids; and (11) preparation of amino acids or their salts by coupling of amino alcohols with water and a base. (12) preparation of amides (including formamides, cyclic dipeptides, diamide, lactams, polypeptides and polyamides) by dehydrogenative coupling of alcohols and amines; (13) preparation of imides from diols.

  本发明涉及新型锰配合物及其用途，包括但不限于在以下领域进行均相催化：（1）通过醇和胺的脱氢偶联制备亚胺；（2）使用腈作为迈克尔供体进行迈克尔加成反应中的C-C偶联；（3）将醇脱氢偶联以得到酯和氢气；（4）将酯加氢以形成醇（包括环酯（内酯）或环二酯（二内酯）或聚酯的加氢）；（5）将酰胺（包括环二肽、内酰胺、二酰胺、多肽和聚酰胺）加氢以得到醇和胺（或二胺）；（6）将有机碳酸酯（包括聚碳酸酯）加氢以得到醇或将氨基甲酸酯（包括聚氨基甲酸酯）或脲衍生物加氢以得到醇和胺；（7）将二级醇脱氢以得到酮；（8）酯的酰胺化（即从酯和胺合成酰胺）；（9）使用酯对醇进行酰化；（10）将醇与水和碱偶联以形成羧酸；以及（11）通过氨基醇与水和碱的偶联制备氨基酸或其盐。（12）通过醇和胺的脱氢偶联制备酰胺（包括甲酰胺、环二肽、二酰胺、内酰胺、多肽和聚酰胺）；（13）从二醇制备酰亚胺。